NEW YORK (360Dx) – Abbott said today that the US Food and Drug Administration has granted a CLIA waiver for use of its reformulated rapid influenza diagnostic test, BinaxNOW Influenza A & B Card 2, with the firm's Digival diagnostic reader for the rapid detection of influenza virus.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.